The integration of alcohol screening, treatment and referral into primary care and other medical settings is not routinely done. Nor are there any studies evaluating the effectiveness of integrating care for alcohol use disorders (AUDs) into routine treatment for tuberculosis (TB), despite the high co-occurrence and mortality associated with these two diseases.

A scientist who is helping to treat thousands of people living with HIV and tuberculosis (TB) in South Africa was awarded the Royal Society Pfizer Award at a ceremony last night (27 October). Dr Linda-Gail Bekker's research looks at how TB epidemiology has changed in the HIV era. Researchers estimate that more than one in ten of all South Africans over 2 years old were living with HIV in 2008. South Africa has also seen a six fold increase in tuberculosis rates in the last 20 years.

The British Veterinary Association (BVA) has welcomed the TB Eradication (Wales) Order 2009, laid today, which will give the Welsh Assembly Government the legal powers to use culling and vaccination of badgers as part of the tuberculosis eradication programme in Wales. The move comes after a 14-week public consultation carried out by the Welsh Assembly Government.

HIV-Positive Babies More Likely To Contract Deadly TB If Given BCG A three-year study in South Africa found that babies who were born HIV-positive had a higher risk of contracting a deadly form of tuberculosis if given the widely used BCG vaccine, the

A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology they describe how HIV interferes with the cellular and molecular mechanisms used by the lungs to fight TB infection.

Tuberculosis (TB) experts at Johns Hopkins have evidence from a four-year series of experiments in mice that anti-inflammatory drugs could eventually prove effective in treating the highly contagious lung disease, adding to current antibiotic therapies.

A blueprint for a much-needed new generation of tuberculosis (TB) treatment has been developed by a team of scientists led at the University of Strathclyde in Glasgow. TB was once thought to have been eradicated but has become a major killer again in recent years, claiming two million lives annually - or one every fifteen seconds - and infecting about a third of the world's population.

A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical company, has been announced at the Pacific Health Summit in response to the urgent need to accelerate the discovery and development of new drugs to fight tuberculosis (TB).

Future Studies Needed To Determine If 'Test And Treat' Approach Could 'End HIV Pandemic Within 50 Years,' Researchers Say In a Journal of the American Medical Association